肺腺癌在长期佩姆布利祖马布治疗期间接种SARS-CoV-2疫苗后的尺寸减小:一个病例报告

Koki Fujii1, Kensuke Fukuda1, Masanori Kawakami1

  • 1Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo, Japan.

Case reports in oncology
|October 30, 2023
PubMed
概括

这项案例研究表明,癌症免疫力在长期免疫检查点抑制剂治疗期间可能会持续存在. 在肺腺癌患者中使用 pembrolizumab 治疗可能允许进一步的免疫激活,即使在接种了 COVID-19 疫苗后.

相关概念视频

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
383
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K